Clinical Evidence
A Published, Peer-Reviewed Randomized Controlled Trial
A factorial randomized controlled trial of 120 elderly patients with type 2 diabetes tested four approaches: standard care alone, standard care plus a medication adherence device (MedpeR®), standard care plus a clinical pharmacological review, and standard care plus both combined. The trial ran May–December 2023 and was published in the Journal of Diabetology in October–December 2024.
Standard care alone (control)
70.0%
Adherence rate
MedpeR® + standard care
73.1%
Adherence rate
Clinical pharmacological review + standard care
75.3%
Adherence rate
MedpeR® + clinical pharmacological review combined
82.1%
Highest-performing arm
Citation
Samajdar SS, Tripathi R, Mukherjee S, Biswas K, Joshi SR, Sarkar S, Tripathi SK, Saboo B. Improving medication adherence in geriatric T2DM patients: A factorial randomized controlled trial. Journal of Diabetology 2024;15:389–94.
DOI: 10.4103/jod.jod_85_24 · CTRI Registration: CTRI/2023/10/058703 · Ethics approval: HREC-AARC/33 · Published by Wolters Kluwer / Medknow
📄 Read Full Article →This was a pilot-scale study (30 patients per arm). The authors themselves note that future research should assess diverse populations and long-term sustainability — a normal and expected next step for a trial at this stage, not a limitation specific to MedpeR®.
Also Discussed in Peer-Reviewed Literature
The following peer-reviewed reviews discuss MedpeR® as an example of innovative adherence technology within a broader survey of the field. These are literature reviews, not independent studies of MedpeR® — the RCT above remains the primary clinical evidence.
Medication Adherence in the Elderly: A Comprehensive Review
Samajdar SS, Tripathi R, Venkatraman S, Mukherjee S, Pal J, Tripathi SK, Joshi SR, Maheshwari A. National Journal of Pharmacology and Therapeutics 2024;2:143–7.
DOI: 10.4103/NJPT.NJPT_60_24 · Published by Wolters Kluwer / Medknow
📄 Read Full Article →
Bridging the Gap: Innovative Strategies to Enhance Medication Adherence in Cardiovascular Disease Management
Samajdar SS, Joshi SR, Chakraborty S, Sarkar S, Banerjee S, Maheshwari A, Tewari A, Singh NK. Public Health Discourse, Vol. 1, Issue 1, Oct–Dec 2024.
Official journal of the Centre for Public Health and Hygiene Research (CPHHR)
📄 Read Full Article →Conference Abstracts
Ahead of the factorial RCT above, an earlier single-site pilot evaluation of MedpeR® (30 urban elderly patients, 2-arm design) was presented at two conferences. This pilot is a separate, smaller study from the published trial — presented here as part of the same ongoing research programme, not as additional evidence for the published results.
Advancing Medication Adherence in India: Validating MedpeR® — Your Personal Medicinal helpeR
ESPACOMP 2024 — 28th Annual Conference of the European Society for Patient Adherence, COMpliance and Persistence (Italy). Published in the ESPACOMP 2024 Official Conference Abstract Book (peer-reviewed proceedings).
📄 View Abstract (PDF) →Advancing Medication Adherence in India: Validating MedpeR® — A Novel Assistive Technology Focused on the Diabetic and Elderly
MIDCON 2025 — Annual Conference of RSSDI, West Bengal Chapter. Published in International Journal of Diabetes and Technology, Vol. 4, Supplement 2 (June 2025).
📄 View Abstract (PDF) →Featured in Books
MedpeR® and its clinical research team are featured across the following medical textbooks.
Diabetes in Practice: A Comprehensive Guide for Physicians
Authors: Shambo Samrat Samajdar, Rupak Chatterjee, Shashank R Joshi, Jyotirmoy Pal. ISBN 9789366164946, 1st Edition (2025), Jaypee Brothers Medical Publishers. Chapter 14, "Enhancing Medication Adherence in Diabetes through MedPer and CPRRF."
🔗 View Book →
Postgraduate Pharmacology, 2nd Edition
Authors: Sougata Sarkar, Vartika Srivastava, Manjushree Mohanty. Paperback, 19 August 2024.
🔗 View Book →
Practical Pharmacology
Authors: Sougata Sarkar, Vartika Srivastava, Chaitali Pattanayak. Paperback, 17 June 2023.
🔗 View Book →
Skill-Preneurship: Self-Reliant India
Authors: Prof. (Dr.) N. M. Kondap, Dr. R. Kishore Kumar. ISBN 9788195290079, 1st Edition (2022).
🔗 View Book →Regulatory & Intellectual Property
Formally Registered, Patented, and Protected
MedpeR® is manufactured under a registered medical device classification and holds granted patent, design, and trademark protection in India.
Medical Device Registration
CDSCO Class A — Non-Sterile, Non-Measuring Device
Registration No. Inovoc-Kolka-WB/M/MD/031883
Application No. MFG/Class A-NSNM/2026/031886
Central Drugs Standard Control Organisation, Ministry of Health, Government of India
📄 View Registration (PDF) →
Utility Patent
Smart Personalized Electronic Pill Dispenser and Medication Monitoring Device and a System Thereof
Patent No. 568287 · Application No. 201931029876
Filed 24 July 2019 · Granted 1 July 2025 · 20-year term · The Patent Office, Government of India
📄 View Certificate (PDF) →
Design Patent
Smart Medication Container
Design No. 421181-001 · Class 24-01
Registered 26 June 2024 · Issued 25 July 2024 · The Patent Office, Government of India
📄 View Certificate (PDF) →
Registered Trademark
MedpeR® — Word & Logo Mark
Trade Mark No. 4899026 · Class 9 (application software, electronic components)
Registered 9 March 2021 · Trade Marks Registry, Mumbai
📄 View Certificate (PDF) →Featured In
Curated Directories & Media Features
MedpeR® is listed in curated innovation and healthcare directories, and has been featured in video interviews and segments.
Directory Listings
Atlas of TB Innovations
View listing →
Parkinson's UK Tech Guide
View listing →
Safe Seniors
View listing →
Video & Podcast Features
Institutional Recognition
Backed by Leading Institutions
MedpeR® has received research support, incubation, and recognition from national institutions spanning healthcare, technology, and entrepreneurship.
Next Step
Ready to evaluate MedpeR® for your institution?
Share your patient volume and care setting, and our institutional team will respond within 48 working hours with a proposal tailored to your facility.
Request a Facility Demo →